Improvement of image quality of non-invasive coronary artery imaging with magnetic resonance by the use of the intravascular contrast agent Clariscan (NC100150 injection) in patients with coronary artery disease

PURPOSE: To assess the feasibility of Clariscan, an intravascular contrast agent, for free breathing, navigator assisted, high resolution, three-dimensional-magnetic resonance coronary angiography (MRCA) in patients, as extracellular contrast agents are unfavorable for the improvement of image quality. MATERIALS AND METHODS: MRCA was performed in 10 patients with known coronary artery disease (CAD) with (1-5 mg Fe/kg body weight) and without contrast agent. RESULTS: Compared to unenhanced images, Clariscan did not improve signal-to-noise (SNR) or contrast-to-noise ratios (CNR) compared to fat or myocardium in the proximal parts of the coronary arteries. However, when analyzing the peripheral parts (>4 cm from origin), CNR(fat) and CNR(myo) improved up to a factor of 1.81 and 5.85, respectively, at a dose of 3 mg Fe/kg body weight, while SNR did not reach statistical significance. The visible length of the coronary arteries was improved from 49 +/- 18 mm to 73 +/- 33 mm. The proximal diameter was reduced from 3.6 +/- 0.8mm to 3.2 +/- 0.8 mm, representing more closely the diameter of 3.1 +/- 0.7 mm measured by quantitative coronary angiography. Of 11 significant stenoses (>50%), eight were identified in the enhanced compared to six in the unenhanced images. CONCLUSION: The use of Clariscan at a dose of 2-3 mg Fe/kg body weight improves image quality of three-dimensional-MRCA, especially in the peripheral segments, and, thus, the diagnostic accuracy for the detection of CAD.     

Multislice breath-hold spiral magnetic resonance coronary angiography in patients with coronary artery disease: effect of intravascular contrast medium

PURPOSE: First, to apply a breath-hold multislice 2D spiral magnetic resonance (MR) approach in patients acquiring within 16 heartbeats (acquisition window, 116 msec) a 10-mm-thick stack of four slices (resolution, 1.3 x 1.3 mm(2)); and second, to evaluate the effect of an intravascular Fe-based contrast medium (CM) on a signal-to-noise ratio (SNR) and a contrast-to-noise ratio (CNR). MATERIALS AND METHODS: In each patient one or two coronary arteries were imaged prior to and following cumulative doses of 0.25, 0.5, and 0.75 mg of Fe/kg of body weight (bw) of an intravascular CM (CLARISCAN trade mark, Nycomed-Amersham, Princeton, NJ, USA) containing ultrasmall superparamagnetic iron oxide (USPIO) particles. RESULTS: On precontrast maximum intensity projection (MIP) images generated from the stack of slices, 10 and 11 stenoses of 12 stenoses confirmed by coronary angiography were detected by readers 1 and 2, respectively. SNR and CNR in the coronary arteries peaked at 0.50 mg of Fe/kg of bw, yielding a slight increase of 15.5% and 18.4%, respectively (P < 0.05 vs. precontrast), which did not improve detection of coronary artery stenoses. CONCLUSION: The presented multislice spiral approach allows display of coronary anatomy in MIP formats for convenient display of coronary stenoses. The pulse sequence did not benefit from an intravascular USPIO-based CM, since little improvement in SNR and CNR was achieved.     

Improved bulk myocardial motion suppression for navigator-gated coronary magnetic resonance imaging

PURPOSE: To evaluate the impact of a new, cross-correlation based method for compensation of respiratory induced motion of the heart using an individually adapted three-dimensional (3D) translation or affine transformation approach. MATERIALS AND METHODS: A total of 32 patients underwent a routine cardiac MR examination. In each patient, a calibration scan was performed during free-breathing to register breathing-related motion within a 3D ellipsoid registration kernel covering the entire heart. Three navigators were employed for all three spatial dimensions (feet-head, anterior-posterior, and left-right) and the optimal translatory correction factors for each spatial dimension were determined. In addition, the cross-correlations for different motion models (no compensation, fixed 1D-translation, adapted 3D-translation, and affine transformation) were calculated. RESULTS: The mean correction factor for the feet-head direction was 0.45 +/- 0.13. Though the mean correction factors for the anterior-posterior and left-right direction were nearly zero (-0.01 +/- 0.08 and 0.02 +/- 0.09, respectively), the correction factors exceeded the amount of 0.1 in 12 (19%) and in 19 patients (30%), respectively. All motion compensation models showed significantly higher cross-correlations when compared to "no compensation" (P < 0.05). In particular, the affine transformation algorithm achieved the highest cross-correlation values (88.3 +/- 5.1%) with a significant increase compared to fixed 1D translation (84.7 +/- 6.5%, P < 0.05). CONCLUSION: A considerable number of patients demonstrated relevant breathing-related movement of the heart in the anterior-posterior or left-right direction in addition to the predominant breathing-related movement in the feet-head direction. Thus, it is recommended to compensate for all three spatial dimensions. The affine transformation algorithm combined with three navigators significantly improved breathing-related cardiac motion compensation when compared to the conventionally applied 1D translation with a fixed correction factor.     

Improved three-dimensional free-breathing coronary magnetic resonance angiography using gadocoletic acid (B-22956) for intravascular contrast enhancement

PURPOSE: To evaluate gadocoletic acid (B-22956), a gadolinium-based paramagnetic blood pool agent, for contrast-enhanced coronary magnetic resonance angiography (MRA) in a Phase I clinical trial, and to compare the findings with those obtained using a standard noncontrast T2 preparation sequence. MATERIALS AND METHODS: The left coronary system was imaged in 12 healthy volunteers before B-22956 application and 5 (N = 11) and 45 (N = 7) minutes after application of 0.075 mmol/kg of body weight (BW) of B-22956. Additionally, imaging of the right coronary system was performed 23 minutes after B-22956 application (N = 6). A three-dimensional gradient echo sequence with T2 preparation (precontrast) or inversion recovery (IR) pulse (postcontrast) with real-time navigator correction was used. Assessment of the left and right coronary systems was performed qualitatively (a 4-point visual score for image quality) and quantitatively in terms of signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), vessel sharpness, visible vessel length, maximal luminal diameter, and the number of visible side branches. RESULTS: Significant (P < 0.01) increases in SNR (+42%) and CNR (+86%) were noted five minutes after B-22956 application, compared to precontrast T2 preparation values. A significant increase in CNR (+40%, P < 0.05) was also noted 45 minutes postcontrast. Vessels (left anterior descending artery (LAD), left coronary circumflex (LCx), and right coronary artery (RCA)) were also significantly (P < 0.05) sharper on postcontrast images. Significant increases in vessel length were noted for the LAD (P < 0.05) and LCx and RCA (both P < 0.01), while significantly more side branches were noted for the LAD and RCA (both P < 0.05) when compared to precontrast T2 preparation values. CONCLUSION: The use of the intravascular contrast agent B-22956 substantially improves both objective and subjective parameters of image quality on high-resolution three-dimensional coronary MRA. The increase in SNR, CNR, and vessel sharpness minimizes current limitations of coronary artery visualization with high-resolution coronary MRA.     

Volume‐targeted and whole‐heart coronary magnetic resonance angiography using an intravascular contrast agent

Purpose

To compare volume‐targeted and whole‐heart coronary magnetic resonance angiography (MRA) after the administration of an intravascular contrast agent.

Materials and Methods

Six healthy adult subjects underwent a navigator‐gated and ‐corrected (NAV) free breathing volume‐targeted cardiac‐triggered inversion recovery (IR) 3D steady‐state free precession (SSFP) coronary MRA sequence (t‐CMRA) (spatial resolution = 1 × 1 × 3 mm³) and high spatial resolution IR 3D SSFP whole‐heart coronary MRA (WH‐CMRA) (spatial resolution = 1 × 1 × 2 mm³) after the administration of an intravascular contrast agent B‐22956. Subjective and objective image quality parameters including maximal visible vessel length, vessel sharpness, and visibility of coronary side branches were evaluated for both t‐CMRA and WH‐CMRA.

Results

No significant differences (P = NS) in image quality were observed between contrast‐enhanced t‐CMRA and WH‐CMRA. However, using an intravascular contrast agent, significantly longer vessel segments were measured on WH‐CMRA vs. t‐CMRA (right coronary artery [RCA] 13.5 ± 0.7 cm vs. 12.5 ± 0.2 cm; P < 0.05; and left circumflex coronary artery [LCX] 11.9 ± 2.2 cm vs. 6.9 ± 2.4 cm; P < 0.05). Significantly more side branches (13.3 ± 1.2 vs. 8.7 ± 1.2; P < 0.05) were visible for the left anterior descending coronary artery (LAD) on WH‐CMRA vs. t‐CMRA. Scanning time and navigator efficiency were similar for both techniques (t‐CMRA: 6.05 min; 49% vs. WH‐CMRA: 5.51 min; 54%, both P = NS).

Conclusion

Both WH‐CMRA and t‐CMRA using SSFP are useful techniques for coronary MRA after the injection of an intravascular blood‐pool agent. However, the vessel conspicuity for high spatial resolution WH‐CMRA is not inferior to t‐CMRA, while visible vessel length and the number of visible smaller‐diameter vessels and side‐branches are improved. J. Magn. Reson. Imaging 2009;30:1191–1196. © 2009 Wiley‐Liss, Inc.     

Projection imaging of the right coronary artery with an intravenous injection of contrast agent.

Contrast-enhanced (CE) MR angiography of the right coronary artery (RCA) was performed using 2D thick-slice projection imaging with a small (8 mL) intravenous injection of contrast agent in six volunteers. With a tight contrast bolus injection, the RCA was enhanced for a few seconds after the contrast bolus was washed out of the right ventricle. This allowed data to be acquired when only the RCA was enhanced. Using 2D thick-slice magnetization prepared steady-state free precession (SSFP) imaging, background signal was suppressed and a complete data set was acquired in three heartbeats. A mean vessel length of 7.1 +/- 0.9 cm was depicted with a signal-to-noise ratio of 11.8 +/- 0.7 and contrast-to-noise ratio of 6.1 +/- 0.6. Thick-slice 2D projection CE SSFP is a promising method to depict the RCA.     

Performance of a new gadolinium-based intravascular contrast agent in free-breathing inversion-recovery 3D coronary MRA.

In three-dimensional (3D) coronary magnetic resonance angiography (MRA), the in-flow contrast between the coronary blood and the surrounding myocardium is attenuated as compared to thin-slab two-dimensional (2D) techniques. The application of a gadolinium (Gd)-based intravascular contrast agent may provide an additional source of signal and contrast by reducing T(1blood) and supporting the visualization of more distal or branching segments of the coronary arterial tree. In six healthy adults, the left coronary artery (LCA) system was imaged pre- and postcontrast with a 0.075-mmol/kg bodyweight dose of the intravascular contrast agent B-22956. For imaging, an optimized free-breathing, navigator-gated and -corrected 3D inversion recovery (IR) sequence was used. For comparison, state-of-the-art baseline 3D coronary MRA with T(2) preparation for non-exogenous contrast enhancement was acquired. The combination of IR 3D coronary MRA, sophisticated navigator technology, and B-22956 allowed for an extensive visualization of the LCA system. Postcontrast, a significant increase in both the signal-to-noise ratio (SNR; 46%, P < 0.05) and contrast-to-noise ratio (CNR; 160%, P < 0.01) was observed, while vessel sharpness of the left anterior descending (LAD) artery and the left coronary circumflex (LCX) were improved by 20% (P < 0.05) and 18% (P < 0.05), respectively.     

Evaluation of free-breathing three-dimensional magnetic resonance coronary angiography with hybrid ordered phase encoding (HOPE) for the detection of proximal coronary artery stenosis.

We evaluated free-breathing, prospective navigator-gated, three-dimensional (3D) magnetic resonance coronary angiography (MRCA) with hybrid ordered phase-encoding (HOPE), in the detection of proximal coronary artery stenosis. The coronary arteries were imaged in 46 patients undergoing cardiac catheterization. The mean scan time was 48 minutes. The mean arterial length (mm) visualized was left main stem (LMS) 11.7 (SD 4.5), left anterior descending (LAD) 30.1 (SD 11.1), circumflex (LCx) 15.5 (SD 8.6), and right (RCA) 56.2 (SD 20.8). Twenty-three patients had coronary artery disease with 47 significant stenoses on cardiac catheterization. All LMS were normal on both catheterization and MRCA. MRCA sensitivity was highest for the LAD (89% CI 65%-99%) and RCA (76% CI 50%-93%), but lower for the LCx (50% CI 21%-79%). Specificity ranged from 72%-100%. Improvements in image quality, length of vessel seen, and specific imaging of the LCx are required for MRCA to become an alternative to cardiac catheterization.     

Cardiac fat navigator-gated steady-state free precession 3D magnetic resonance angiography of coronary arteries.

Motion artifacts and the lack of accurate detection of cardiac motion present a major challenge for high-resolution cardiac MRI. Recently a multidimensional cardiac fat navigator was proposed to provide a fast and direct measurement of bulk cardiac motion. The objective of this study was to demonstrate the feasibility of employing the cardiac fat navigator in balanced steady-state free precession (SSFP) free-breathing 3D coronary MRA (CMRA). The cardiac fat navigator echo is optimized to provide both motion monitoring and epicardial fat suppression. Steady-state magnetization preparation, which is needed for SSFP CMRA, is optimized by comparing three preparation schemes: alpha/2, linear ramp with 20 RF pulses (20LR), and Kaiser ramp with six RF pulses (6KR). The present preliminary human study shows that the 6KR preparation provides better image quality than both the alpha/2 (P<0.0025) and the 20LR preparations (P<0.025) for free-breathing SSFP 3D CMRA (N=11).     

Short breath-hold, volumetric coronary MR angiography employing steady-state free precession in conjunction with parallel imaging.

An ECG-gated, 3D steady-state free precession (SSFP) technique in conjunction with sensitivity encoding (SENSE)-based parallel imaging was implemented for short breath-hold, volumetric coronary MR angiograpy (CMRA). Two parallel imaging acquisition strategies (employing 1 R-R and 2 R-R intervals, respectively) were developed to achieve 1) very short breath-hold times (12 s for a heart rate of 60 bpm), and 2) small acquisition windows to minimize sensitivity to physiologic motion. Both strategies were examined in CMRA applications over a range of heart rates. A four-point scale blinded reading (with 4 indicating the most desirable features) revealed substantial image quality improvements for the accelerated data as compared to the nonaccelerated approach. The 1 R-R interval scheme yielded an image score of 3.39 +/- 0.60, and was found to be particularly suitable for low heart rates (P = 0.0008). The 2 R-R interval strategy yielded an image score of 3.35 +/- 0.64, and was more appropriate for higher heart rates (P = 0.03). The results demonstrate that 3D SSFP combined with parallel imaging is a versatile method for short breath-hold CMRA while maintaining high spatial resolution. This strategy permits imaging of the major coronary artery distributions in two to three breath-holds using targeted slabs, and offers the potential for single breath-hold, large-volume CMRA.     

Motion of the distal renal artery during three-dimensional contrast-enhanced breath-hold MRA

PURPOSE: To study the potential detrimental effects of renal motion on breath-hold three-dimensional contrast-enhanced (CE) magnetic resonance angiography (MRA). MATERIALS AND METHODS: A computer model simulating linear motion was applied to MRA pulse sequences. Subsequently, to study whether renal motion was present, 24 patients being evaluated for possible renovascular hypertension underwent a breath-hold nonenhanced single slice two-dimensional dynamic turbo field-echo magnetic resonance imaging (MRI) scan with a typical duration of 32 seconds. This sequence was followed by breath-hold three-dimensional CE renal MRA. CE-MRA images were evaluated by two independent observers. RESULTS: The computer model revealed linear renal motion to cause artifacts. The severity of these artifacts correlated with velocity. Significant (P < 0.001) near linear cranial motion of the kidneys and diaphragm during a sustained breath-hold was found for the right kidney, left kidney, right diaphragm, and left diaphragm (0.26 +/- 0.21 mm/second, 0.25 +/- 0.23 mm/second, 0.43 +/- 0.43 mm/second, and 0.29 +/- 0.33 mm/second [mean +/- SD], respectively). CE-MRA images showed artifacts of the distal renal artery that corroborated the computer model findings. CONCLUSION: The observed cranial motion of the kidneys during a breath-hold adversely affects distal renal artery image quality on three-dimensional CE-MRA and jeopardizes reliable clinical evaluation. Shortening scan time may be beneficial for decreasing image degradation caused by this phenomenon.     

Whole-heart steady-state free precession coronary artery magnetic resonance angiography.

Current implementations of coronary artery magnetic resonance angiography (MRA) suffer from limited coverage of the coronary arterial system. Whole-heart coronary MRA was implemented based on a free-breathing steady-state free-precession (SSFP) technique with magnetization preparation. The technique was compared to a similar implementation of conventional, thin-slab coronary MRA in 12 normal volunteers. Three thin-slab volumes were prescribed: 1) a transverse slab, covering the left main (LM) artery and proximal segments of the left anterior ascending (LAD) and left circumflex (LCX) coronary arteries; 2) a double-oblique slab covering the right coronary artery (RCA); and 3) a double-oblique slab covering the proximal and distal segments of the LCX. The whole-heart data set was reformatted in identical orientations. Visible vessel length, vessel sharpness, and vessel diameter were determined and compared separately for each vessel. Whole-heart coronary MRA visualized LM/LAD (11.7 +/- 3.4 cm) and LCX (6.9 +/- 3.6 cm) over a significantly longer distance than the transverse volume (LM/LAD, 6.1 +/- 1.1 cm, P < 0.001; LCX, 4.2 +/- 1.2 cm, P < 0.05). Improvements in visible vessel length for RCA and LCX in the whole-heart approach vs. their respective targeted volumes were not significant. It is concluded that the whole-heart coronary MRA technique improves visible vessel length and facilitates high-quality coronary MRA of the complete coronary artery tree in a single measurement.     

Spiral coronary angiography using a blood pool agent

PURPOSE: To experimentally investigate the optimum dose of an iron-oxide-based blood pool agent for spiral coronary MR angiography (MRA), and the difference between single and multiple spiral excitations in each cardiac cycle. MATERIALS AND METHODS: Images using single and triple spiral excitations in each cardiac cycle were obtained in late diastole of the left main coronary artery in eight pigs following an inversion prepulse. Measurements were obtained before and after injection of increasing doses of an iron oxide blood pool agent (Clariscan) corresponding to concentrations of 0.8, 2.2, and 3.9 mg Fe/kg BW. The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were measured. RESULTS: For 0.8 mg Fe/kg BW relative to precontrast values, a significant increase was observed for both one (SNR: 2.3, CNR: 3.8) and three (SNR: 1.4, CNR: 2.2) excitations (P < 0.01). When the dose was increased from 0.8 mg Fe/kg BW to 2.2 mg Fe/kg BW, only the SNR (P < 0.01) increased further. Significantly higher CNR (1.6-1.8) and SNR (1.4-1.6) values were seen for one excitation relative to three excitations at all concentrations (P < 0.05). CONCLUSION: At low concentrations, an iron oxide blood pool agent can increase SNR and CNR significantly with both single excitation and triple excitations using an inversion-prepared spiral acquisition scheme. At higher concentrations, T2* effects reduce image quality.     

First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent

PURPOSE: To evaluate the feasibility of first-pass contrast-enhanced magnetic resonance angiography (MRA) using ferumoxytol in humans. MATERIALS AND METHODS: First-pass and equilibrium phase MRA were performed using ferumoxytol in one healthy volunteer and 11 patients with a fast three-dimensional spoiled gradient recalled (SPGR) pulse sequence. The examined vessels included carotid arteries, thoracic aorta, abdominal aorta, and peripheral arteries. A dose of either 71.6 micromol Fe/kg (n = 9), or 35.8 micromol Fe/kg (n = 3) was used. Based on a phantom study, the agent with initial concentration of 537.2 micromol Fe/mL was diluted by either four-fold (134.3 micromol Fe/mL) or eight-fold (67.1 micromol Fe/mL) for first-pass MRA. RESULTS: All subjects completed their studies without adverse events. First-pass MRA showed selective arterial enhancement, with both arterial and venous enhancement on delayed acquisitions. Selective venous enhancement could be obtained by subtraction of arterial phase images from equilibrium phase images. The findings in ferumoxytol MRA were consistent with the results of original vascular tests. CONCLUSION: Our preliminary experience supports the feasibility of first-pass MRA with ferumoxytol. Satisfactory arterial enhancement during first-pass imaging is obtained with injection of diluted contrast agent. With ferumoxytol, arteries and veins can be selectively depicted in a single exam.     

Whole-heart coronary magnetic resonance angiography at 3 Tesla in 5 minutes with slow infusion of Gd-BOPTA, a high-relaxivity clinical contrast agent.

T(1)-shortening contrast agents have been used to improve the depiction of coronary arteries with breath-hold magnetic resonance angiography (MRA). The spatial resolution and coverage are limited by the duration of the arterial phase of the contrast media passage. In this study we investigated the feasibility of acquiring free-breathing, whole-heart coronary MRA during slow infusion of the contrast media (0.3 ml/s) for prolonged blood signal enhancement time. Ultrashort TR (3 ms) and parallel data acquisition were used to allow the whole-heart MRA in approximately 5 min. A newly approved gadolinium (Gd)-based high T(1) relaxivity contrast agent, gadobenate dimeglumine ([Gd-BOPTA](2-)), was used and coronary MRA was performed on a whole-body 3 Tesla (T) system to improve the signal-to-noise ratio (SNR). Results from eight volunteers demonstrate that this coronary MRA method is capable of imaging the whole heart in 4.5 +/- 0.6 min. Major coronary arteries are well depicted with high SNR (42.4 +/- 12.5) and contrast-to-noise ratio (CNR; 27.1 +/- 7.6).     

Contrast agent dose effects in cerebral dynamic susceptibility contrast magnetic resonance perfusion imaging

Purpose

To study the contrast agent dose sensitivity of hemodynamic parameters derived from brain dynamic susceptibility contrast MRI (DSC‐MRI).

Materials and Methods

Sequential DSC‐MRI (1.5T gradient‐echo echo‐planar imaging using an echo time of 61–64 msec) was performed using contrast agent doses of 0.1 and 0.2 mmol/kg delivered at a fixed rate of 5.0 mL/second in 12 normal subjects and 12 stroke patients.

Results

1) Arterial signal showed the expected doubling in relaxation response (ΔR2*) to dose doubling. 2) The brain signal showed a less than doubled ΔR2* response to dose doubling. 3) The 0.2 mmol/kg dose studies subtly underestimated cerebral blood volume (CBV) and cerebral blood flow (CBF) relative to the 0.1 mmol/kg studies. 4) In the range of low CBV and CBF, the 0.2 mmol/kg studies overestimated the CBV and CBF compared with the 0.1 mmol/kg studies. 5) The 0.1 mmol/kg studies reported larger ischemic volumes in stroke.

Conclusion

Subtle but statistically significant dose sensitivities were found. Therefore, it is advisable to carefully control the contrast agent dose when DSC‐MRI is used in clinical trials. The study also suggests that a 0.1 mmol/kg dose is adequate for hemodynamic measurements. J. Magn. Reson. Imaging 2009;29:52–64. © 2008 Wiley‐Liss, Inc.     

Self‐tracking of contrast kinetics for automatic triggering of contrast‐enhanced whole‐heart coronary magnetic resonance angiography

Purpose

To develop a method for automatically triggering centric data acquisition during contrast‐enhanced whole‐heart coronary magnetic resonance angiography (MRA).

Materials and Methods

The hypothesis of this work is that the blood signal changes during contrast infusion can be estimated by obtaining a projection of the heart during inversion‐recovery prepared data acquisition. A validation study was performed on seven healthy volunteers to test this hypothesis. The peak blood signal enhancement detected from the projection was then used to automatically trigger the start of central k‐space data acquisition. Simulations were performed to compare the signal‐to‐noise ratio (SNR) of the proposed self‐triggering method with the fixed delay method. Six healthy volunteers were scanned on a 3T MR system using the proposed self‐triggered method to test its effectiveness on coronary artery visualization.

Results

Based on the validation study, the self‐triggering method provides an accurate representation of the contrast enhancement. Based on the simulations, self‐triggering with centric ordering is expected to give a 27% higher SNR than linear ordering with a fixed imaging delay. Self‐triggering was successfully used in all volunteers and showed excellent depiction of the major coronary arteries.

Conclusion

The self‐triggering method can be used to automatically determine the optimal delay time for central k‐space acquisition, for each individual subject, without the need of any extra setup or user interaction. J. Magn. Reson. Imaging 2009;29:809–816. © 2009 Wiley‐Liss, Inc.     

Coronary MR angiography using citrate‐coated very small superparamagnetic iron oxide particles as blood‐pool contrast agent: Initial experience in humans

Purpose:

To evaluate very small superparamagnetic iron oxide particles (VSOP‐C184) as blood‐pool contrast agent for coronary MR angiography (CMRA) in humans.

Materials and Methods:

Six healthy volunteers and 14 patients with suspected coronary artery disease underwent CMRA after administration of VSOP‐C184 at the following doses: 20 μmol Fe/kg (4 patients), 40 μmol Fe/kg (5 patients), 45 μmol Fe/kg (6 healthy volunteers), and 60 μmol Fe/kg (5 patients). In healthy volunteers, contrast‐to‐noise ratio (CNR), signal‐to‐noise ratio (SNR), and vessel edge definition (VED) of contrast‐enhanced CMRA were compared with non–contrast‐enhanced CMRA. In patients, a per‐segment intention‐to‐diagnose evaluation of contrast‐enhanced CMRA for detection of significant coronary stenosis (≥50%) was performed.

Results:

Three healthy volunteers (45 μmol Fe/kg VSOP‐C184) and two patients (60 μmol Fe/kg VSOP‐C184) had adverse events of mild or moderate intensity. VSOP‐C184 significantly increased CNR (15.1 ± 4.6 versus 6.9 ± 1.9; P = 0.010), SNR (21.7 ± 5.3 versus 15.4 ± 1.6; P = 0.048), and VED (2.3 ± 0.6 versus 1.2 ± 0.2; P < 0.001) compared with non–contrast‐enhanced CMRA. In patients, contrast‐enhanced CMRA yielded sensitivity, specificity, and diagnostic accuracy for detection of significant coronary stenosis of 86.7%, 71.0%, 73.1%, respectively.

Conclusion:

CMRA using VSOP‐C184 was feasible and yielded moderate diagnostic accuracy for detection of significant coronary stenosis within this proof‐of‐concept setting. J. Magn. Reson. Imaging 2011;. © 2011 Wiley‐Liss, Inc.     

On the dual contrast enhancement mechanism in frequency‐selective inversion‐recovery magnetic resonance angiography (IRON‐MRA)

The susceptibility of blood changes after administration of a paramagnetic contrast agent that shortens T₁. Concomitantly, the resonance frequency of the blood vessels shifts in a geometry‐dependent way. This frequency change may be exploited for incremental contrast generation by applying a frequency‐selective saturation prepulse prior to the imaging sequence. The dual origin of vascular enhancement depending first on off‐resonance and second on T₁ lowering was investigated in vitro, together with the geometry dependence of the signal at 3T. First results obtained in an in vivo rabbit model are presented. Magn Reson Med, 2009. © 2009 Wiley‐Liss, Inc.     

Contrast-enhanced 4D radial coronary artery imaging at 3.0 T within a single breath-hold.

Coronary magnetic resonance angiography data are usually acquired during mid-diastole of each heartbeat to minimize cardiac motion related artifacts. The proper trigger delay time, which may vary widely among subjects, must be determined individually for each subject before data acquisition to achieve optimal image quality. These complications could be resolved by acquiring contiguous cardiac phase images through the cardiac cycle. In this study, we used a radial sampling technique to acquire 3D cine coronary artery images at 3 T within a single breath-hold. An extravascular, paramagnetic contrast agent was i.v. administered to improve the blood signal intensity. Relatively high temporal resolution and spatial resolution were achieved simultaneously with radial sampling, parallel data acquisition, and interleaved sliding window image reconstruction. Volunteer studies demonstrate the feasibility of this technique in acquiring 4D coronary artery images and the flexibility in postprocessing of 3D image sets.